With a U.S.population of 3.1 million sufferers of IBD including (Crohns disease and Ulcerative Colitis) among others.
The TAM is about $20.53 Billion with a growth factor of 5.5%...a solid CAGR between Now and 2032.
SOLD at $57.00 PPS...after much haggling since 2020.